table of contents
Stromal cell-derived factor-1alpha (SDF-1alpha) has pleiotropic effects on hematopoietic progenitor …
Biology Articles » Biotechnology » Red Biotechnology » The Many Facets of SDF-1alpha CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells » References
- The Many Facets of SDF-1alpha CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells
- K. Imai, M. Kobayashi, and J. Wang, et al., “Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow,” British Journal of Haematology, vol. 106, no. 4, pp. 905–911, 1999.
- A. Dar, P. Goichberg, and V. Shinder, et al., “Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells,” Nature Immunology, vol. 6, no. 10, pp. 1038–1046, 2005.
- M. Shirozu, T. Nakano, and J. Inazawa, et al., “Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene,” Genomics, vol. 28, no. 3, pp. 495–500, 1995.
- T. Shioda, H. Kato, and Y. Ohnishi, et al., “Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6331–6336, 1998.
- S. M. de La Luz, F. Yang, and M. Narazaki, et al., “Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity,” Blood, vol. 103, no. 7, pp. 2452–2459, 2004.
- I. Petit, P. Goichberg, and A. Spiegel, et al., “Atypical PKC-ζ regulates SDF-1-mediated migration and development of human CD34+ progenitor cells,” Journal of Clinical Investigation, vol. 115, no. 1, pp. 168–176, 2005.
- R. Möhle, F. Bautz, S. Rafii, M. A. S. Moore, W. Brugger, and L. Kanz, “The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1,” Blood, vol. 91, no. 12, pp. 4523–4530, 1998.
- C. H. Kim and H. E. Broxmeyer, “In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment,” Blood, vol. 91, no. 1, pp. 100–110, 1998.
- J. P. Chute, “Stem cell homing,” Current Opinion in Hematology, vol. 13, no. 6, pp. 399–406, 2006.
- S. Fruehauf, K. Srbic, R. Seggewiss, J. Topaly, and A. D. Ho, “Functional characterization of podia formation in normal and malignant hematopoietic cells,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 425–432, 2002.
- S. Tavor, I. Petit, and S. Porozov, et al., “Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice,” Blood, vol. 106, no. 6, pp. 2120–2127, 2005.
- J.-J. Lataillade, D. Clay, and C. Dupuy, et al., “Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival,” Blood, vol. 95, no. 3, pp. 756–768, 2000.
- J.-J. Lataillade, D. Clay, and P. Bourin, et al., “Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism,” Blood, vol. 99, no. 4, pp. 1117–1129, 2002.
- Y. Lee, A. Gotoh, and H.-J. Kwon, et al., “Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines,” Blood, vol. 99, no. 12, pp. 4307–4317, 2002.
- J. Kijowski, M. Baj-Krzyworzeka, and M. Majka, et al., “The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells,” Stem Cells, vol. 19, no. 5, pp. 453–466, 2001.
- H. E. Broxmeyer, L. Kohli, and C. H. Kim, et al., “Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gαi proteins and enhances engraftment of competitive, repopulating stem cells,” Journal of Leukocyte Biology, vol. 73, no. 5, pp. 630–638, 2003.
- K. Hattori, B. Heissig, and K. Tashiro, et al., “Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells,” Blood, vol. 97, no. 11, pp. 3354–3360, 2001.
- C. C. Bleul, M. Farzan, and H. Choe, et al., “The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry,” Nature, vol. 382, no. 6594, pp. 829–833, 1996.
- J.-I. Yamaguchi, K. F. Kusano, and O. Masuo, et al., “Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization,” Circulation, vol. 107, no. 9, pp. 1322–1328, 2003.
- J.-F. Wang, I.-W. Park, and J. E. Groopman, “Stromal cell-derived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C,” Blood, vol. 95, no. 8, pp. 2505–2513, 2000.
- P. Goichberg, A. Kalinkovich, and N. Borodovsky, et al., “cAMP-induced PKC-ζ activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors,” Blood, vol. 107, no. 3, pp. 870–879, 2006.
- C. Tudan, G. E. Willick, and S. Chahal, et al., “C-terminal cyclization of an SDF-1 small peptide analogue dramatically increases receptor affinity and activation of the CXCR4 receptor,” Journal of Medicinal Chemistry, vol. 45, no. 10, pp. 2024–2031, 2002.
- S. Villalba, O. Salvucci, and Y. Aoki, et al., “Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-1 infection in vivo,” Journal of Leukocyte Biology, vol. 74, no. 5, pp. 880–888, 2003.
- K. Li, C. K. Y. Chuen, and S. M. Lee, et al., “Small peptide analogue of SDF-1α supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice,” Stem Cells, vol. 24, no. 1, pp. 55–64, 2006.
- R. Zhong, P. Law, D. Wong, A. Merzouk, H. Salari, and E. D. Ball, “Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells,” Experimental Hematology, vol. 32, no. 5, pp. 470–475, 2004.
- E. de Clercq, “Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100,” Mini-Reviews in Medicinal Chemistry, vol. 5, no. 9, pp. 805–824, 2005.
- H. E. Broxmeyer, C. M. Orschell, and D. W. Clapp, et al., “Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist,” Journal of Experimental Medicine, vol. 201, no. 8, pp. 1307–1318, 2005.
- S. Fruehauf, T. Seeger, and P. Maier, et al., “The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics,” Experimental Hematology, vol. 34, no. 8, pp. 1052–1059, 2006.
- W. Wagner, A. Ansorge, and U. Wirkner, et al., “Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis,” Blood, vol. 104, no. 3, pp. 675–686, 2004.
- S. Huang, P. Law, K. Francis, B. O. Palsson, and A. D. Ho, “Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules,” Blood, vol. 94, no. 8, pp. 2595–2604, 1999.
- M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie, and C. M. Verfaillie, “Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells,” Blood, vol. 98, no. 9, pp. 2615–2625, 2001.
- W. Wagner, F. Wein, and A. Seckinger, et al., “Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood,” Experimental Hematology, vol. 33, no. 11, pp. 1402–1416, 2005.
- W. Wagner, R. E. Feldmann Jr., and A. Seckinger, et al., “The heterogeneity of human mesenchymal stem cell preparations - Evidence from simultaneous analysis of proteomes and transcriptomes,” Experimental Hematology, vol. 34, no. 4, pp. 536–548, 2006.
- W. Wagner, F. Wein, and C. Roderburg, et al., “Adhesion of hematopoietic progenitor cells to human mesenchymal stromal cells as a model for cell-cell interaction,” Experimental Hematology, vol. 35, no. 2, pp. 314–325, 2007.
- W. Holloway, A. R. Martinez, D. J. Oh, K. Francis, R. Ramakrishna, and B. O. Palsson, “Key adhesion molecules are present on long podia extended by hematopoietic cells,” Cytometry, vol. 37, no. 3, pp. 171–177, 1999.
- D. J. Oh, A. R. Martinez, G. M. Lee, K. Francis, and B. O. Palsson, “Intercellular adhesion can be visualized using fluorescently labeled fibrosarcoma HT1080 cells cocultured with hematopoietic cell lines or CD34+ enriched human mobilized peripheral blood cells,” Cytometry, vol. 40, no. 2, pp. 119–125, 2000.
- A. E. Frimberger, C. I. McAuliffe, and K. A. Werme, et al., “The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia,” British Journal of Haematology, vol. 112, no. 3, pp. 644–654, 2001.
- W. Wagner, R. Saffrich, and U. Wirkner, et al., “Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction,” Stem Cells, vol. 23, no. 8, pp. 1180–1191, 2005.
- J. D. van Buul, C. Voermans, J. van Gelderen, E. C. Anthony, C. E. van der Schoot, and P. L. Hordijk, “Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4,” Journal of Biological Chemistry, vol. 278, no. 32, pp. 30302–30310, 2003.
- M. J. Orsini, J.-L. Parent, S. J. Mundell, J. L. Benovic, and A. Marchese, “Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization,” Journal of Biological Chemistry, vol. 274, no. 43, pp. 31076–31086, 1999.
- A. Sachpatzidis, B. K. Benton, and J. P. Manfredi, et al., “Identification of allosteric peptide agonists of CXCR4,” Journal of Biological Chemistry, vol. 278, no. 2, pp. 896–907, 2003.
- A. Aiuti, I. J. Webb, C. Bleul, T. Springer, and J. C. Gutierrez-Ramos, “The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood,” Journal of Experimental Medicine, vol. 185, no. 1, pp. 111–120, 1997.
- D. E. Wright, E. P. Bowman, A. J. Wagers, E. C. Butcher, and I. L. Weissman, “Hematopoietic stem cells are uniquely selective in their migratory response to chemokines,” Journal of Experimental Medicine, vol. 195, no. 9, pp. 1145–1154, 2002.
- A. Avigdor, P. Goichberg, and S. Shivtiel, et al., “CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow,” Blood, vol. 103, no. 8, pp. 2981–2989, 2004.
- A. Larochelle, A. Krouse, and M. Metzger, et al., “AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates,” Blood, vol. 107, no. 9, pp. 3772–3778, 2006.
- S. Basu and H. E. Broxmeyer, “Transforming growth factor-β1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12,” Blood, vol. 106, no. 2, pp. 485–493, 2005.
- N. Wright, T. L. de Lera, and C. García-Moruja, et al., “Transforming growth factor-β1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion,” Blood, vol. 102, no. 6, pp. 1978–1984, 2003.
- R. F. Wynn, C. A. Hart, and C. Corradi-Perini, et al., “A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow,” Blood, vol. 104, no. 9, pp. 2643–2645, 2004.
- S. Bhakta, P. Hong, and O. Koc, “The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation,” Cardiovascular Revascularization Medicine, vol. 7, no. 1, pp. 19–24, 2006.
- B.-R. Son, L. A. Marquez-Curtis, and M. Kucia, et al., “Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases,” Stem Cells, vol. 24, no. 5, pp. 1254–1264, 2006.
- S. Hatse, K. Princen, and K. Vermeire, et al., “Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry,” FEBS Letters, vol. 546, no. 2-3, pp. 300–306, 2003.
- S. P. Forde, T. B. Jorgensen, and S. E. Newey, et al., “Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells,” Blood, vol. 109, no. 5, pp. 1825–1833, 2007.
- D. A. Sipkins, X. Wei, and J. W. Wu, et al., “In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment,” Nature, vol. 435, no. 7044, pp. 969–973, 2005.
- J. A. Burger and T. J. Kipps, “CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment,” Blood, vol. 107, no. 5, pp. 1761–1767, 2006.
rating: 2.00 from 2 votes | updated on: 13 Dec 2007 | views: 10241 |